Hideaki Miyake (Makito Miyake, Takuya Owari)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Benign Prostatic Hyperplasia

Muscle Invasive Bladder Cancer

Patients Undergoing

Top Venues

International journal of urology : official journal of the Japanese Urological Association

This page only lists publications with an associated author ORCID identifier.

Publications

Tatsuki Miyamoto, Makito Miyake, Tomonori Nakahama, Nobutaka Nishimura, Kenta Onishi, Kouta Iida, Masaya Yonemori, Hideki Enokida, Masayuki Nakagawa, Hiroaki Matsumoto, Hideyasu Matsuyama, Yuto Matsushita, Hideaki Miyake, Tomomi Fujii, Keiji Shimada, Satoshi Baba, Mitsuru Kinjyo, Tatsuro Shimokama, Koji Okumura, Kiyohide Fujimoto, null null
Validation of the risk stratification newly defined in the Japanese Urological Association guidelines 2019 for non-muscle invasive bladder cancer: A multi-institutional collaborative study. International journal of urology : official journal of the Japanese Urological Association (2023)
Nobumichi Tanaka, Yasushi Nakai, Isao Asakawa, Kaori Yamaki, Makito Miyake, Shunta Hori, Hideaki Miyake, Tomomi Fujii, Kiyohide Fujimoto
Local dose (biologically effective dose ≥180 Gy2) is an important predictor of biochemical recurrence in patients undergoing low-dose-rate brachytherapy. International journal of urology : official journal of the Japanese Urological Association (2022)
Shunta Hori, Mitsuru Tomizawa, Tatsuo Yoneda, Yasushi Nakai, Hideaki Miyake, Kiyohide Fujimoto
Clinical and emotional factors for the acceptance or refusal of deceased-donor kidney transplantation in patients on waiting lists during the coronavirus disease 2019 pandemic. International journal of urology : official journal of the Japanese Urological Association 29 (5) (2022)
Hideaki Miyake, Nobumichi Tanaka, Yasushi Nakai, Makito Miyake, Satoshi Anai, Kazumasa Torimoto, Fumisato Maesaka, Isao Asakawa, Kaori Yamaki, Tomomi Fuji, Masatoshi Hasegawa, Kiyohide Fujimoto
Impact of neoadjuvant androgen deprivation therapy on postimplant prostate D90 and prostate volume after low-dose-rate brachytherapy for localized prostate cancer. International journal of urology : official journal of the Japanese Urological Association (2021)